Scanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAID (CC BY 2.0)
FDA Approves First CAR T Cell Treatment for Acute Lymphoblastic Leukemia
August 30, 2017
“We are incredibly excited to see a CAR T-cell treatment come to patients in the United States,” Dr. Helen E. Heslop, ASGCT President and Director of the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital says. “This remarkable approval is the beginning of what we see as a chance to transform the way in which we treat cancer.”
Cell & Gene Therapy Approval
|
Kymriah
|
Policy Updates
Read Full Story